| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | T5RCK09KHV |
| InChI Key | KXSUAWAUCNFBQJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H15FN2 |
| Molecular Weight | 230.29 |
| AlogP | 3.0 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 28.68 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 17.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Adrenergic receptor alpha-2 antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | - | - | 14 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 150586-58-6 |
| ChEMBL | CHEMBL1255582 |
| DrugBank | DB06585 |
| FDA SRS | T5RCK09KHV |
| PubChem | 213041 |
| SureChEMBL | SCHEMBL18826053 |